Skip to content

PMV Pharmaceuticals Inc Sustainability Reports

PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG007NM4862

4 reports from 2020 to 2024